Emerald Development Managers — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams.
AI & Machine LearningBiotechHealthtechMedical DevicesPhiladelphia, US
David West, Jr.(Executive Officer, Director)David West(Founder)inDavid West, Sr.(Executive Officer, Director)Coleman Stavish(Founder)Nathan Buchbinder(Founder)
BoardAlex Niehenke(Director)in
Co-investorsAlpha Intelligence CapitalFlybridge Capital PartnersFusionGreen Park & Golf VenturesHitachi VenturesInterwoven Ventures+9 more
Random Power develops true random number generators derived from silicon detector technology originally created for particle physics research at CERN.
CybersecurityDeep TechHardwareQuantum ComputingSemiconductors
Co-investorsLIFTTDeep Ocean Capital SGR S.P.A.Deep Ocean Capital SGR S.p.A.
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Una Software
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








